139 related articles for article (PubMed ID: 2845043)
1. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations.
Graziano JH; Lolacono NJ; Meyer P
J Pediatr; 1988 Oct; 113(4):751-7. PubMed ID: 2845043
[TBL] [Abstract][Full Text] [Related]
2. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of edetate calcium disodium and dimercaptosuccinic acid in the treatment of lead poisoning in adults.
Sakthithasan K; Lévy P; Poupon J; Garnier R
Clin Toxicol (Phila); 2018 Nov; 56(11):1143-1149. PubMed ID: 29889577
[TBL] [Abstract][Full Text] [Related]
4. 2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
Graziano JH; Siris ES; LoIacono N; Silverberg SJ; Turgeon L
Clin Pharmacol Ther; 1985 Apr; 37(4):431-8. PubMed ID: 2983924
[TBL] [Abstract][Full Text] [Related]
5. Treatment of lead poisoning by 2,3-dimercaptosuccinic acid.
Friedheim E; Graziano JH; Popovac D; Dragovic D; Kaul B
Lancet; 1978 Dec; 2(8102):1234-6. PubMed ID: 82738
[TBL] [Abstract][Full Text] [Related]
6. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
7. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
Bradberry S; Sheehan T; Vale A
QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
[TBL] [Abstract][Full Text] [Related]
8. Combined therapeutic potential of meso-2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats.
Flora SJ; Bhattacharya R; Vijayaraghavan R
Fundam Appl Toxicol; 1995 May; 25(2):233-40. PubMed ID: 7665007
[TBL] [Abstract][Full Text] [Related]
9. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of combined chelation in lead intoxication.
Tandon SK; Singh S; Jain VK
Chem Res Toxicol; 1994; 7(5):585-9. PubMed ID: 7841335
[TBL] [Abstract][Full Text] [Related]
11. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.
Schwartz BS; Lee BK; Stewart W; Sithisarankul P; Strickland PT; Ahn KD; Kelsey K
Occup Environ Med; 1997 Apr; 54(4):241-6. PubMed ID: 9166129
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning.
Besunder JB; Super DM; Anderson RL
J Pediatr; 1997 Jun; 130(6):966-71. PubMed ID: 9202621
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures.
Chisolm JJ
Environ Health Perspect; 1990 Nov; 89():67-74. PubMed ID: 1965166
[TBL] [Abstract][Full Text] [Related]
14. Effects of calcium disodium EDTA and meso-2,3-dimercaptosuccinic acid on tissue concentrations of lead for use in treatment of calves with experimentally induced lead toxicosis.
Meldrum JB; Ko KW
Am J Vet Res; 2003 Jun; 64(6):672-6. PubMed ID: 12828250
[TBL] [Abstract][Full Text] [Related]
15. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data.
Thurtle N; Greig J; Cooney L; Amitai Y; Ariti C; Brown MJ; Kosnett MJ; Moussally K; Sani-Gwarzo N; Akpan H; Shanks L; Dargan PI
PLoS Med; 2014 Oct; 11(10):e1001739. PubMed ID: 25291378
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined administration of calcium, iron, zinc, chrysanthemum flavonoids, and DMSA on the treatment of lead intoxication in mice.
Huali T; Honglei P; Feng W; Shaokang W; Ligang Y; Jianghong L; Guiju S
J Biochem Mol Toxicol; 2020 Feb; 34(2):e22425. PubMed ID: 31729815
[TBL] [Abstract][Full Text] [Related]
17. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning.
Haust HL; Inwood M; Spence JD; Poon HC; Peter F
Clin Biochem; 1989 Jun; 22(3):189-96. PubMed ID: 2544323
[TBL] [Abstract][Full Text] [Related]
19. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.
Glotzer DE
Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892
[TBL] [Abstract][Full Text] [Related]
20. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
Besunder JB; Anderson RL; Super DM
Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
